Hip fracture readmissions lower when nursing home in sync with hospital staff: study
By
Alicia Lasek
Apr 14, 2022
A collaboration between nursing home staff and hospital clinicians helped reduce readmission and mortality rates and improved quality of life for residents with hip fracture.
Black patients less likely to seek hospice care than whites, researchers say
By
Alicia Lasek
Oct 29, 2020
Black patients seek substantially more intensive medical treatment in the last six months of life than whites, a study shows. The investigators recommend that more healthcare providers are trained to promote...
U.S. Senate committee urged to follow SNFs’ lead in falls prevention
By
Alicia Lasek
Oct 16, 2019
Lawmakers should consider changes to Medicare and look to nursing facilities’ experience when addressing fall-related injuries in seniors, says LeadingAge.
Clinical Briefs for Tuesday, July 21
By
Alicia Lasek
Jul 21, 2020
Oldest, most frail adults may benefit from hospitalization for COVID-19, study finds … Coronavirus vaccine trial a ‘major breakthrough,’ claims drugmaker … Quest Diagnostics is first to gain...
Low-dose brain radiation improves behavior, cognition in Alzheimer’s pilot study
By
Alicia Lasek
May 04, 2021
Low-dose ionizing radiation may be a promising, although possibly controversial, therapy for Alzheimer’s disease, according to the researchers behind a small new pilot study.
Survey: U.S. neurologists would prescribe Leqembi if fully approved
By
Alicia Lasek
Apr 12, 2023
A “healthy proportion” of surveyed neurologists have already begun prescribing the treatment, and nearly all said they planned to do so if traditional FDA approval is granted.
Becerra orders CMS to rethink $22 Medicare Part B premium price hike tied to Aduhelm
By
Alicia Lasek
Jan 11, 2022
With the 50% price drop of Aduhelm on January 1, there is good reason for CMS to reassess a hefty proposed premium hike for 2022, the U.S. health secretary said. On Wednesday, CMS is expected to announce...
Benefits of Alzheimer’s drug Leqembi persist when treatment is halted, trial shows
By
Alicia Lasek
Apr 09, 2023
A relative slowing of cognitive decline continues for up to two years in patients who stop taking the recently authorized drug, clinical trial data reveal.
Program that diagnosed fractures virtually led to fewer ER visits for LTC residents: study
By
Alicia Lasek
May 14, 2023
A program that enabled virtual diagnosis and on-site fracture care kept 100% of participating LTC residents out of the emergency department and cut the need for clinic visits, a new study reveals.
Pfizer, BioNTech to pursue 2nd booster shot authorization for older adults
By
Alicia Lasek
Mar 16, 2022
A second booster — or fourth dose — will be necessary to improve the vaccine’s waning protection in the face of omicron, Pfizer’s CEO has stated. Whether the FDA will find the evidence compelling...